Physical inactivity as risk factor for mortality by diabetes mellitus in Brazil in 1990, 2006, and 2016.
Burden of disease
Diabetes
Hyperglycemia
Morbidity
Mortality
Physical activity
Journal
Diabetology & metabolic syndrome
ISSN: 1758-5996
Titre abrégé: Diabetol Metab Syndr
Pays: England
ID NLM: 101488958
Informations de publication
Date de publication:
2019
2019
Historique:
received:
17
09
2018
accepted:
22
02
2019
entrez:
15
3
2019
pubmed:
15
3
2019
medline:
15
3
2019
Statut:
epublish
Résumé
The aims of this study were to estimate the mortality due to diabetes mellitus attributed to physical inactivity in Brazil, to analyze these estimate in three points in time (1990, 2006 and, 2016), and to analyze these estimates according to the socioeconomic status of Brazilian states. All deaths and diseases recorded in Brazil during this period were analyzed. Surveys of the general adult population using random sampling procedures evaluating self-reported physical activity in all life domains in Brazil were included. The total number and the age-standardized rates of deaths, and population-attributable fraction (PAF) for diabetes mellitus attributed to physical inactivity in the years 1990, 2006, and 2016 were estimated. Socioeconomic Development Index (SDI) was used as an indicator of socioeconomic status of Brazilian states. In relation to mortality due to diabetes mellitus attributed to physical inactivity, 736 deaths were estimated in 1990, 1337 deaths were estimated in 2006, and 1897 in 2016, which represented, in 1990, an age-standardized mortality rate (per 100,000 inhabitants) of 1.2, 2.1 in 2006, and 1.1 in 2016. Approximately 3.0% (PAF) of deaths due to diabetes mellitus could be avoided if the Brazilian population were physically active. In 2006 and 2016, Brazilian states with worst socioeconomic indicators had higher age-standardized mortality rate by diabetes mellitus due to physical inactivity. These findings are the first to estimate the burden of diabetes mellitus due to physical inactivity in Brazil and support the promotion of physical activity in the Brazilian population to prevent and manage diabetes mellitus.
Sections du résumé
BACKGROUND
BACKGROUND
The aims of this study were to estimate the mortality due to diabetes mellitus attributed to physical inactivity in Brazil, to analyze these estimate in three points in time (1990, 2006 and, 2016), and to analyze these estimates according to the socioeconomic status of Brazilian states.
METHODS
METHODS
All deaths and diseases recorded in Brazil during this period were analyzed. Surveys of the general adult population using random sampling procedures evaluating self-reported physical activity in all life domains in Brazil were included. The total number and the age-standardized rates of deaths, and population-attributable fraction (PAF) for diabetes mellitus attributed to physical inactivity in the years 1990, 2006, and 2016 were estimated. Socioeconomic Development Index (SDI) was used as an indicator of socioeconomic status of Brazilian states.
RESULTS
RESULTS
In relation to mortality due to diabetes mellitus attributed to physical inactivity, 736 deaths were estimated in 1990, 1337 deaths were estimated in 2006, and 1897 in 2016, which represented, in 1990, an age-standardized mortality rate (per 100,000 inhabitants) of 1.2, 2.1 in 2006, and 1.1 in 2016. Approximately 3.0% (PAF) of deaths due to diabetes mellitus could be avoided if the Brazilian population were physically active. In 2006 and 2016, Brazilian states with worst socioeconomic indicators had higher age-standardized mortality rate by diabetes mellitus due to physical inactivity.
CONCLUSION
CONCLUSIONS
These findings are the first to estimate the burden of diabetes mellitus due to physical inactivity in Brazil and support the promotion of physical activity in the Brazilian population to prevent and manage diabetes mellitus.
Identifiants
pubmed: 30867683
doi: 10.1186/s13098-019-0419-9
pii: 419
pmc: PMC6396532
doi:
Types de publication
Journal Article
Langues
eng
Pagination
23Références
Popul Health Metr. 2010 May 10;8:9
pubmed: 20459720
Eur J Nutr. 2013 Feb;52(1):237-46
pubmed: 22302615
Am J Prev Med. 2013 Sep;45(3):269-75
pubmed: 23953352
Best Pract Res Clin Endocrinol Metab. 2013 Aug;27(4):501-7
pubmed: 24054927
Circulation. 2013 Nov 12;128(20):2259-79
pubmed: 24126387
Global Health. 2013 Dec 03;9:62
pubmed: 24299125
Diabetes Metab Syndr Obes. 2015 Jan 05;8:17-28
pubmed: 25609989
Diabetes Care. 2015 Aug;38(8):1536-43
pubmed: 26015557
Eur J Epidemiol. 2015 Jul;30(7):529-42
pubmed: 26092138
BMC Public Health. 2015 Aug 11;15:772
pubmed: 26259708
Diabetol Metab Syndr. 2015 Nov 26;7:109
pubmed: 26617678
Eur J Epidemiol. 2016 Oct;31(10):967-997
pubmed: 27485519
BMJ. 2016 Aug 09;354:i3857
pubmed: 27510511
Ethn Health. 2017 Aug;22(4):372-388
pubmed: 27748135
Diabetol Metab Syndr. 2017 Mar 14;9:18
pubmed: 28293304
Sao Paulo Med J. 2017 Jan-Feb;135(1):1-3
pubmed: 28380172
Rev Saude Publica. 2017 Jun 01;51(suppl 1):3s
pubmed: 28591351
Rev Bras Epidemiol. 2017 May;20Suppl 01(Suppl 01):21-33
pubmed: 28658370
Rev Bras Epidemiol. 2017 May;20Suppl 01(Suppl 01):34-45
pubmed: 28658371
Rev Bras Epidemiol. 2017 May;20Suppl 01(Suppl 01):90-101
pubmed: 28658375
Med Hypotheses. 2017 Jul;104:147-153
pubmed: 28673573
Int J Public Health. 2018 May;63(Suppl 1):177-186
pubmed: 28776240
Lancet. 2017 Sep 16;390(10100):1084-1150
pubmed: 28919115
Lancet. 2017 Sep 16;390(10100):1151-1210
pubmed: 28919116
Lancet. 2017 Sep 16;390(10100):1345-1422
pubmed: 28919119
Diabetes Res Clin Pract. 2018 Apr;138:271-281
pubmed: 29496507
Sci Rep. 2018 Jul 24;8(1):11141
pubmed: 30042430